#BEGIN_DRUGCARD DB02431

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
65-47-4

# ChEBI_ID:
17677

# Chemical_Formula:
C9H16N3O14P3

# Chemical_IUPAC_Name:
({[({[(2S,3R,4R,5R)-5-(4-amino-2-oxo-1,2-dihydropyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Cytidine 5&#39;-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety. [PubChem]

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Cytidine-5'-Triphosphate

# HET_ID:
CTP

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C9H16N3O14P3/c10-5-1-2-12(9(15)11-5)8-7(14)6(13)4(24-8)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h1-2,4,6-8,13-14H,3H2,(H,19,20)(H,21,22)(H2,10,11,15)(H2,16,17,18)/t4-,6-,7+,8+/m0/s1

# InChI_Key:
InChIKey=PCDQPRRSZKQHHS-ZAKLUEHWSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C00063

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2431

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
483.1563

# Molecular_Weight_Mono:
482.984511771

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1VPA

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.34

# Predicted_LogS:
-1.6

# Predicted_Water_Solubility:
1.12e+01 g/l

# Primary_Accession_No:
DB02431

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
6602106

# PubChem_Substance_ID:
46507556

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01053

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC(=O)N(C=C1)[C@@H]1O[C@@H](CO[P@](O)(=O)O[P@@](O)(=O)OP(O)(O)=O)[C@H](O)[C@H]1O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:08 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Not Available

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
cca

# Drug_Target_1_Gene_Sequence:
Not Available

# Drug_Target_1_General_Function:
Involved in RNA binding

# Drug_Target_1_General_References:
Not Available

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4676

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
45370

# Drug_Target_1_Name:
CCA-adding enzyme

# Drug_Target_1_Number_of_Residues:
404

# Drug_Target_1_PDB_ID:
1MIY

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01743	PolyA_pol

# Drug_Target_1_Protein_Sequence:
>CCA-adding enzyme
MKPPFQEALGIIQQLKQHGYDAYFVGGAVRDLLLGRPIGDVDIATSALPEDVMAIFPKTI
DVGSKHGTVVVVHKGKAYEVTTFKTDGDYEDYRRPESVTFVRSLEEDLKRRDFTMNAIAM
DEYGTIIDPFGGREAIRRRIIRTVGEAEKRFREDALRMMRAVRFVSELGFALAPDTEQAI
VQNAPLLAHISVERMTMEMEKLLGGPFAARALPLLAETGLNAYLPGLAGKEKQLRLAAAY
RWPWLAAREERWALLCHALGVQESRPFLRAWKLPNKVVDEAGAILTALADIPRPEAWTNE
QLFSAGLERALSVETVRAAFTGAPPGPWHEKLRRRFASLPIKTKGELAVNGKDVIEWVGK
PAGPWVKEALDAIWRAVVNGEVENEKERIYAWLMERNRTREKNC

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Catalyzes the addition and repair of the essential 3'- terminal CCA sequence in tRNAs without using a nucleic acid template. Adds these three nucleotides in the order of C, C, and A to the tRNA nucleotide-73, using CTP and ATP as substrates and producing inorganic pyrophosphate

# Drug_Target_1_SwissProt_ID:
Q7SIB1

# Drug_Target_1_SwissProt_Name:
CCA_GEOSE

# Drug_Target_1_Synonyms:
EC 2.7.7.21
EC 2.7.7.25
tRNA CCA-pyrophosphorylase
tRNA adenylyl-/cytidylyl- transferase
tRNA nucleotidyltransferase
tRNA-NT

# Drug_Target_1_Theoretical_pI:
8.61

# Drug_Target_1_Transmembrane_Regions:
None

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
Not Available

# Drug_Target_2_Drug_References:
Not Available

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
X56793

# Drug_Target_2_GenBank_ID_Protein:
Not Available

# Drug_Target_2_GeneCard_ID:
Not Available

# Drug_Target_2_Gene_Name:
rfbF

# Drug_Target_2_Gene_Sequence:
>774 bp
ATGAAAGCGGTCATCCTGGCTGGTGGACTTGGTACCAGACTAAGTGAAGAAACAATTGTA
AAACCAAAACCGATGGTAGAAATTGGTGGCAAGCCTATTCTTTGGCACATTATGAAAATG
TATTCTGTGCATGGTATCAAGGATTTTATTATCTGCTGTGGTTATAAAGGATATGTGATT
AAAGAATATTTTGCGAACTACTTCCTTCACATGTCAGATGTAACATTCCATATGGCTGAA
AACCGTATGGAAGTTCACCATAAACGTGTTGAACCATGGAATGTCACATTGGTTGATACG
GGTGATTCTTCAATGACTGGTGGTCGTCTGAAACGTGTTGCTGAATACGTAAAAGATGAC
GAGGCTTTCCTGTTTACTTATGGTGATGGCGTTGCCGACCTTGATATCAAAGCGACTATC
GATTTCCATAAGGCTCACGGTAAGAAAGCGACTTTAACAGCTACTTTTCCACCAGGACGC
TTTGGCGCATTAGATATCCGAGCTGGTCAGGTCCGGTCATTCCAGGAAAAACCGAAAGGC
GATGGGGCAATGATCAATGGTGGTTTCTTTGTGTTGAATCCATCGGTTATCGATCTCATC
GATAACGATGCAACAACCTGGGAACAAGAGCCATTAATGACATTGGCACAACAGGGGGAG
TTAATGGCTTTTGAACACCCAGGTTTCTGGCAGCCGATGGATACCCTACGTGATAAAGTT
TACCTCGAAGGGCTGTGGGAAAAAGGTAAAGCTCCGTGGAAAACCTGGGAGTAA

# Drug_Target_2_General_Function:
Involved in nucleotidyltransferase activity

# Drug_Target_2_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
1710759	Jiang XM, Neal B, Santiago F, Lee SJ, Romana LK, Reeves PR: Structure and sequence of the rfb (O antigen) gene cluster of Salmonella serovar typhimurium (strain LT2). Mol Microbiol. 1991 Mar;5(3):695-713.

# Drug_Target_2_HGNC_ID:
Not Available

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
4677

# Drug_Target_2_Locus:
Not Available

# Drug_Target_2_Molecular_Weight:
29036

# Drug_Target_2_Name:
Glucose-1-phosphate cytidylyltransferase

# Drug_Target_2_Number_of_Residues:
257

# Drug_Target_2_PDB_ID:
1WVC

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF00483	NTP_transferase

# Drug_Target_2_Protein_Sequence:
>Glucose-1-phosphate cytidylyltransferase
MKAVILAGGLGTRLSEETIVKPKPMVEIGGKPILWHIMKMYSVHGIKDFIICCGYKGYVI
KEYFANYFLHMSDVTFHMAENRMEVHHKRVEPWNVTLVDTGDSSMTGGRLKRVAEYVKDD
EAFLFTYGDGVADLDIKATIDFHKAHGKKATLTATFPPGRFGALDIRAGQVRSFQEKPKG
DGAMINGGFFVLNPSVIDLIDNDATTWEQEPLMTLAQQGELMAFEHPGFWQPMDTLRDKV
YLEGLWEKGKAPWKTWE

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
CTP + alpha-D-glucose 1-phosphate = diphosphate + CDP-glucose

# Drug_Target_2_SwissProt_ID:
P26396

# Drug_Target_2_SwissProt_Name:
RFBF_SALTY

# Drug_Target_2_Synonyms:
CDP-glucose pyrophosphorylase
EC 2.7.7.33

# Drug_Target_2_Theoretical_pI:
6.61

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Not Available

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_3_Essentiality:
Non-Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AE000512

# Drug_Target_3_GenBank_ID_Protein:
4981955

# Drug_Target_3_GeneCard_ID:
Not Available

# Drug_Target_3_Gene_Name:
ispD

# Drug_Target_3_Gene_Sequence:
>669 bp
ATGAACGTAGCGATTCTCCTTGCAGCGGGAAAAGGTGAAAGAATGTCTGAAAACGTTCCA
AAACAGTTCCTCGAGATAGAGGGAAGGATGCTTTTCGAGTATCCGCTTTCCACGTTTTTG
AAAAGTGAAGCGATAGATGGTGTTGTGATAGTGACACGAAGAGAGTGGTTCGAAGTTGTA
GAGAAAAGAGTGTTCCACGAAAAAGTACTCGGAATTGTCGAGGGTGGAGATACACGAAGC
CAGAGTGTGAGAAGCGCCCTCGAATTTCTTGAAAAGTTCTCTCCCTCTTACGTTCTCGTA
CACGACTCAGCACGGCCGTTTCTGAGGAAGAAACACGTGTCGGAGGTTCTCAGAAGAGCC
CGCGAAACGGGAGCGGCAACCCTCGCGTTGAAGAATTCCGACGCGCTCGTAAGAGTTGAG
AACGACAGAATAGAATACATCCCAAGAAAAGGAGTGTACAGAATTCTTACACCGCAGGCT
TTTTCTTACGAGATTTTGAAAAAGGCCCATGAAAATGGTGGCGAATGGGCAGACGACACG
GAACCTGTTCAAAAGCTCGGAGTGAAAATAGCCTTGGTCGAGGGAGATCCTTTGTGTTTC
AAAGTGACGTTTAAAGAAGACCTGGAACTGGCGAGAATCATCGCCAGAGAATGGGAGAGG
ATACCATGA

# Drug_Target_3_General_Function:
Lipid transport and metabolism

# Drug_Target_3_General_References:
10360571	Nelson KE, Clayton RA, Gill SR, Gwinn ML, Dodson RJ, Haft DH, Hickey EK, Peterson JD, Nelson WC, Ketchum KA, McDonald L, Utterback TR, Malek JA, Linher KD, Garrett MM, Stewart AM, Cotton MD, Pratt MS, Phillips CA, Richardson D, Heidelberg J, Sutton GG, Fleischmann RD, Eisen JA, White O, Salzberg SL, Smith HO, Venter JC, Fraser CM: Evidence for lateral gene transfer between Archaea and bacteria from genome sequence of Thermotoga maritima. Nature. 1999 May 27;399(6734):323-9.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
3344

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
25371

# Drug_Target_3_Name:
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase

# Drug_Target_3_Number_of_Residues:
222

# Drug_Target_3_PDB_ID:
1VPA

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF01128	IspD

# Drug_Target_3_Protein_Sequence:
>2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
MNVAILLAAGKGERMSENVPKQFLEIEGRMLFEYPLSTFLKSEAIDGVVIVTRREWFEVV
EKRVFHEKVLGIVEGGDTRSQSVRSALEFLEKFSPSYVLVHDSARPFLRKKHVSEVLRRA
RETGAATLALKNSDALVRVENDRIEYIPRKGVYRILTPQAFSYEILKKAHENGGEWADDT
EPVQKLGVKIALVEGDPLCFKVTFKEDLELARIIAREWERIP

# Drug_Target_3_Reaction:
CTP + 2-C-methyl-D-erythritol 4-phosphate = diphosphate + 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Catalyzes the formation of 4-diphosphocytidyl-2-C- methyl-D-erythritol from CTP and 2-C-methyl-D-erythritol 4- phosphate (MEP)

# Drug_Target_3_SwissProt_ID:
Q9X1B3

# Drug_Target_3_SwissProt_Name:
ISPD_THEMA

# Drug_Target_3_Synonyms:
4-diphosphocytidyl-2C-methyl-D-erythritol synthase
EC 2.7.7.60
MCT
MEP cytidylyltransferase

# Drug_Target_3_Theoretical_pI:
7.66

# Drug_Target_3_Transmembrane_Regions:
None

# Drug_Target_4_Cellular_Location:
Cytoplasm

# Drug_Target_4_Chromosome_Location:
Not Available

# Drug_Target_4_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_4_Essentiality:
Non-Essential

# Drug_Target_4_GenAtlas_ID:
Not Available

# Drug_Target_4_GenBank_ID_Gene:
M57497

# Drug_Target_4_GenBank_ID_Protein:
143723

# Drug_Target_4_GeneCard_ID:
Not Available

# Drug_Target_4_Gene_Name:
tagD

# Drug_Target_4_Gene_Sequence:
>390 bp
TTATAAACCAGCAATTTCCTCTTTGATCTTTGTTGTAGAGATGCCTTCTGTTCTTGGGAG
GTAAACAACCTCACACTGATCTTTGAGAAAGTCAAATTTACCTTCCCAGTCATCCCCCAT
AACAAAAACATCAATATTATGATCAATAATATCTTGCTTTTTTTGCTCCCAATTCTTTTC
AGGAATTACTTCGTCCACATATCGAATGGTTTCTAAAATTAATTTACGGTGCTCATAGCT
GTGATAAGCTTTTTTTTGCTTTTGTAAATTGAATTCATCCGTTGAAATAGCAACAACTAA
ATAATCACCAAGCTGCTTTGCACGCTCAAGCAATTTAATGTGACCCCAATGCAGTAAATC
AAAAGTTCCATATGTGATAACTTTTTTCAT

# Drug_Target_4_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_4_General_References:
10508782	Weber CH, Park YS, Sanker S, Kent C, Ludwig ML: A prototypical cytidylyltransferase: CTP:glycerol-3-phosphate cytidylyltransferase from bacillus subtilis. Structure. 1999 Sep 15;7(9):1113-24.
11487587	Sanker S, Campbell HA, Kent C: Negative cooperativity of substrate binding but not enzyme activity in wild-type and mutant forms of CTP:glycerol-3-phosphate cytidylyltransferase. J Biol Chem. 2001 Oct 12;276(41):37922-8. Epub 2001 Aug 3.
1906926	Mauel C, Young M, Karamata D: Genes concerned with synthesis of poly(glycerol phosphate), the essential teichoic acid in Bacillus subtilis strain 168, are organized in two divergent transcription units. J Gen Microbiol. 1991 Apr;137(4):929-41.
8393871	Park YS, Sweitzer TD, Dixon JE, Kent C: Expression, purification, and characterization of CTP:glycerol-3-phosphate cytidylyltransferase from Bacillus subtilis. J Biol Chem. 1993 Aug 5;268(22):16648-54.
9182537	Park YS, Gee P, Sanker S, Schurter EJ, Zuiderweg ER, Kent C: Identification of functional conserved residues of CTP:glycerol-3-phosphate cytidylyltransferase. Role of histidines in the conserved HXGH in catalysis. J Biol Chem. 1997 Jun 13;272(24):15161-6.
9384377	Kunst F, Ogasawara N, Moszer I, Albertini AM, Alloni G, Azevedo V, Bertero MG, Bessieres P, Bolotin A, Borchert S, Borriss R, Boursier L, Brans A, Braun M, Brignell SC, Bron S, Brouillet S, Bruschi CV, Caldwell B, Capuano V, Carter NM, Choi SK, Codani JJ, Connerton IF, Danchin A, et al.: The complete genome sequence of the gram-positive bacterium Bacillus subtilis. Nature. 1997 Nov 20;390(6657):249-56.

# Drug_Target_4_HGNC_ID:
Not Available

# Drug_Target_4_HPRD_ID:
Not Available

# Drug_Target_4_ID:
2991

# Drug_Target_4_Locus:
Not Available

# Drug_Target_4_Molecular_Weight:
15272

# Drug_Target_4_Name:
Glycerol-3-phosphate cytidylyltransferase

# Drug_Target_4_Number_of_Residues:
129

# Drug_Target_4_PDB_ID:
1N1D

# Drug_Target_4_Pathway:
Not Available

# Drug_Target_4_Pfam_Domain_Function:
PF01467	CTP_transf_2

# Drug_Target_4_Protein_Sequence:
>Glycerol-3-phosphate cytidylyltransferase
MKKVITYGTFDLLHWGHIKLLERAKQLGDYLVVAISTDEFNLQKQKKAYHSYEHRKLILE
TIRYVDEVIPEKNWEQKKQDIIDHNIDVFVMGDDWEGKFDFLKDQCEVVYLPRTEGISTT
KIKEEIAGL

# Drug_Target_4_Reaction:
CTP + sn-glycerol 3-phosphate = diphosphate + CDP-glycerol

# Drug_Target_4_Signals:
None

# Drug_Target_4_Specific_Function:
Provides activated glycerol phosphate for teichoic acid synthesis, via incorporation into both the linkage unit and the teichoic acid polymer by tagB and tagF

# Drug_Target_4_SwissProt_ID:
P27623

# Drug_Target_4_SwissProt_Name:
TAGD_BACSU

# Drug_Target_4_Synonyms:
CDP-glycerol pyrophosphorylase
EC 2.7.7.39
GCT
Gro- PCT
Teichoic acid biosynthesis protein D

# Drug_Target_4_Theoretical_pI:
6.01

# Drug_Target_4_Transmembrane_Regions:
None

# Drug_Target_5_Cellular_Location:
Not Available

# Drug_Target_5_Chromosome_Location:
Not Available

# Drug_Target_5_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_5_Essentiality:
Non-Essential

# Drug_Target_5_GenAtlas_ID:
Not Available

# Drug_Target_5_GenBank_ID_Gene:
AF230736

# Drug_Target_5_GenBank_ID_Protein:
7239372

# Drug_Target_5_GeneCard_ID:
Not Available

# Drug_Target_5_Gene_Name:
ispD

# Drug_Target_5_Gene_Sequence:
>711 bp
ATGGCAACCACTCATTTGGATGTTTGCGCCGTGGTTCCGGCGGCCGGATTTGGCCGTCGA
ATGCAAACGGAATGTCCTAAGCAATATCTCTCAATCGGTAATCAAACCATTCTTGAACAC
TCGGTGCATGCGCTGCTGGCGCATCCCCGGGTGAAACGTGTCGTCATTGCCATAAGTCCT
GGCGATAGCCGTTTTGCACAACTTCCTCTGGCGAATCATCCGCAAATCACCGTTGTAGAT
GGCGGTGATGAGCGTGCCGATTCCGTGCTGGCAGGTCTGAAAGCCGCTGGCGACGCGCAG
TGGGTATTGGTGCATGACGCCGCTCGTCCTTGTTTGCATCAGGATGACCTCGCGCGATTG
TTGGCGTTGAGCGAAACCAGCCGCACGGGGGGGATCCTCGCCGCACCAGTGCGCGATACT
ATGAAACGTGCCGAACCGGGCAAAAATGCCATTGCTCATACCGTTGATCGCAACGGCTTA
TGGCACGCGCTGACGCCGCAATTTTTCCCTCGTGAGCTGTTACATGACTGTCTGACGCGC
GCTCTAAATGAAGGCGCGACTATTACCGACGAAGCCTCGGCGCTGGAATATTGCGGATTC
CATCCTCAGTTGGTCGAAGGCCGTGCGGATAACATTAAAGTCACGCGCCCGGAAGATTTG
GCACTGGCCGAGTTTTACCTCACCCGAACCATCCATCAGGAGAATACATAA

# Drug_Target_5_General_Function:
Lipid transport and metabolism

# Drug_Target_5_General_References:
10518523	Rohdich F, Wungsintaweekul J, Fellermeier M, Sagner S, Herz S, Kis K, Eisenreich W, Bacher A, Zenk MH: Cytidine 5'-triphosphate-dependent biosynthesis of isoprenoids: YgbP protein of Escherichia coli catalyzes the formation of 4-diphosphocytidyl-2-C-methylerythritol. Proc Natl Acad Sci U S A. 1999 Oct 12;96(21):11758-63.
11427897	Richard SB, Bowman ME, Kwiatkowski W, Kang I, Chow C, Lillo AM, Cane DE, Noel JP: Structure of 4-diphosphocytidyl-2-C- methylerythritol synthetase involved in mevalonate- independent isoprenoid biosynthesis. Nat Struct Biol. 2001 Jul;8(7):641-8.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_5_HGNC_ID:
Not Available

# Drug_Target_5_HPRD_ID:
Not Available

# Drug_Target_5_ID:
3019

# Drug_Target_5_Locus:
Not Available

# Drug_Target_5_Molecular_Weight:
25738

# Drug_Target_5_Name:
2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase

# Drug_Target_5_Number_of_Residues:
236

# Drug_Target_5_PDB_ID:
1INI

# Drug_Target_5_Pathway:
Not Available

# Drug_Target_5_Pfam_Domain_Function:
PF01128	IspD

# Drug_Target_5_Protein_Sequence:
>2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase
MATTHLDVCAVVPAAGFGRRMQTECPKQYLSIGNQTILEHSVHALLAHPRVKRVVIAISP
GDSRFAQLPLANHPQITVVDGGDERADSVLAGLKAAGDAQWVLVHDAARPCLHQDDLARL
LALSETSRTGGILAAPVRDTMKRAEPGKNAIAHTVDRNGLWHALTPQFFPRELLHDCLTR
ALNEGATITDEASALEYCGFHPQLVEGRADNIKVTRPEDLALAEFYLTRTIHQENT

# Drug_Target_5_Reaction:
CTP + 2-C-methyl-D-erythritol 4-phosphate = diphosphate + 4-(cytidine 5'-diphospho)-2-C-methyl-D-erythritol

# Drug_Target_5_Signals:
None

# Drug_Target_5_Specific_Function:
Catalyzes the formation of 4-diphosphocytidyl-2-C- methyl-D-erythritol from CTP and 2-C-methyl-D-erythritol 4- phosphate (MEP)

# Drug_Target_5_SwissProt_ID:
Q46893

# Drug_Target_5_SwissProt_Name:
ISPD_ECOLI

# Drug_Target_5_Synonyms:
4-diphosphocytidyl-2C-methyl-D-erythritol synthase
CDP-ME synthetase
EC 2.7.7.60
MCT
MEP cytidylyltransferase

# Drug_Target_5_Theoretical_pI:
6.64

# Drug_Target_5_Transmembrane_Regions:
None

# Drug_Target_6_Cellular_Location:
Cytoplasm (Potential)

# Drug_Target_6_Chromosome_Location:
Not Available

# Drug_Target_6_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_6_Essentiality:
Non-Essential

# Drug_Target_6_GenAtlas_ID:
Not Available

# Drug_Target_6_GenBank_ID_Gene:
X74567

# Drug_Target_6_GenBank_ID_Protein:
397407

# Drug_Target_6_GeneCard_ID:
Not Available

# Drug_Target_6_Gene_Name:
kpsU

# Drug_Target_6_Gene_Sequence:
>741 bp
ATGAGCAAAGCAGTTATTGTCATTCCGGCTCGCTATGGCTCCTCGCGCCTGCCGGGTAAG
CCACTGCTCGATATTGTTGGTAAACCGATGATCCAGCATGTTTACGAGCGTGCGTTACAG
GTGGCGGGCGTTGCGGAAGTTTGGGTGGCAACAGACGATCCGCGTGTTGAACAGGCCGTA
CAGGCGTTTGGCGGGAAAGCCATCATGACGCGCAACGATCATGAATCCGGCACCGATCGG
CTGGTCGAGGTGATGCATAAAGTCGAGGCAGATATCTACATTAACCTGCAGGGCGACGAA
CCAATGATTCGCCCGCGGGATGTAGAAACGCTGCTACAAGGAATGCGTGACGATCCCGCG
TTGCCGGTGGCAACGCTATGCCACGCGATTTCTGCCGCAGAAGCGGCTGAGCCAAGCACG
GTAAAAGTGGTTGTGAATACCCGCCAGGATGCGCTTTATTTCAGCCGCTCACCGATTCCG
TATCCGCGTAATGCTGAAAAAGCGCGCTACCTGAAACACGTCGGTATTTACGCTTATCGT
CGCGATGTGCTGCAAAACTACAGCCAGTTACCGGAGTCCATGCCGGAGCAGGCGGAATCA
CTGGAGCAGCTAAGGTTGATGAACGCGGGGATCAACATCCGCACATTTGAGGTTGCCGCA
ACCGGTCCGGGCGTCGACACCCCAGCATGCCTGGAAAAAGTGCGCGCCCTGATGGCACAG
GAACTGGCTGAAAACGCATGA

# Drug_Target_6_General_Function:
Cell wall/membrane/envelope biogenesis

# Drug_Target_6_General_References:
7875563	Rosenow C, Roberts IS, Jann K: Isolation from recombinant Escherichia coli and characterization of CMP-Kdo synthetase, involved in the expression of the capsular K5 polysaccharide (K-CKS). FEMS Microbiol Lett. 1995 Jan 15;125(2-3):159-64.
8397187	Pazzani C, Rosenow C, Boulnois GJ, Bronner D, Jann K, Roberts IS: Molecular analysis of region 1 of the Escherichia coli K5 antigen gene cluster: a region encoding proteins involved in cell surface expression of capsular polysaccharide. J Bacteriol. 1993 Sep;175(18):5978-83.
8706906	Jelakovic S, Jann K, Schulz GE: The three-dimensional structure of capsule-specific CMP: 2-keto-3-deoxy-manno-octonic acid synthetase from Escherichia coli. FEBS Lett. 1996 Aug 5;391(1-2):157-61.

# Drug_Target_6_HGNC_ID:
Not Available

# Drug_Target_6_HPRD_ID:
Not Available

# Drug_Target_6_ID:
2765

# Drug_Target_6_Locus:
Not Available

# Drug_Target_6_Molecular_Weight:
27159

# Drug_Target_6_Name:
3-deoxy-manno-octulosonate cytidylyltransferase

# Drug_Target_6_Number_of_Residues:
246

# Drug_Target_6_PDB_ID:
1GQC

# Drug_Target_6_Pathway:
Not Available

# Drug_Target_6_Pfam_Domain_Function:
PF02348	CTP_transf_3

# Drug_Target_6_Protein_Sequence:
>3-deoxy-manno-octulosonate cytidylyltransferase
MSKAVIVIPARYGSSRLPGKPLLDIVGKPMIQHVYERALQVAGVAEVWVATDDPRVEQAV
QAFGGKAIMTRNDHESGTDRLVEVMHKVEADIYINLQGDEPMIRPRDVETLLQGMRDDPA
LPVATLCHAISAAEAAEPSTVKVVVNTRQDALYFSRSPIPYPRNAEKARYLKHVGIYAYR
RDVLQNYSQLPESMPEQAESLEQLRLMNAGINIRTFEVAATGPGVDTPACLEKVRALMAQ
ELAENA

# Drug_Target_6_Reaction:
CTP + 3-deoxy-D-manno-octulosonate = diphosphate + CMP-3-deoxy-D-manno-octulosonate

# Drug_Target_6_Signals:
None

# Drug_Target_6_Specific_Function:
Activates KDO (a required 8-carbon sugar) for incorporation into bacterial lipopolysaccharide in Gram-negative bacteria

# Drug_Target_6_SwissProt_ID:
P42216

# Drug_Target_6_SwissProt_Name:
KPSU5_ECOLX

# Drug_Target_6_Synonyms:
CKS
CMP-2-keto-3-deoxyoctulosonic acid synthetase
CMP-KDO synthetase
EC 2.7.7.38

# Drug_Target_6_Theoretical_pI:
5.70

# Drug_Target_6_Transmembrane_Regions:
None

# Drug_Target_7_Cellular_Location:
Not Available

# Drug_Target_7_Chromosome_Location:
Not Available

# Drug_Target_7_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_7_Essentiality:
Non-Essential

# Drug_Target_7_GenAtlas_ID:
UCK2

# Drug_Target_7_GenBank_ID_Gene:
D78335

# Drug_Target_7_GenBank_ID_Protein:
1655420

# Drug_Target_7_GeneCard_ID:
UCK2

# Drug_Target_7_Gene_Name:
UCK2

# Drug_Target_7_Gene_Sequence:
>786 bp
ATGGCCGGGGACAGCGAGCAGACCCTGCAGAACCACCAGCAGCCCAACGGCGGCGAGCCC
TTCCTTATAGGCGTCAGCGGGGGAACAGCTAGCGGCAAGTCTTCCGTGTGTGCTAAGATC
GTGCAGCTCCTGGGGCAGAATGAGGTGGACTATCGCCAGAAGCAGGTGGTCATCCTGAGC
CAGGATAGCTTCTACCGTGTCCTTACCTCGGAGCAGAAGGCCAAAGCCCTGAAGGGCCAG
TTCAACTTTGACCACCCGGATGCCTTTGACAATGAACTCATTCTCAAAACACTCAAAGAA
ATCACTGAAGGGAAAACAGTCCAGATCCCCGTGTATGACTTTGTCTCCCATTCCCGGAAG
GAGGAGACAGTTACTGTCTATCCCGCAGACGTGGTGCTCTTTGAAGGGATCCTGGCCTTC
TACTCCCAGGAGGTACGAGACCTGTTCCAGATGAAGCTTTTTGTGGATACAGATGCGGAC
ACCCGGCTCTCACGCAGAGTATTAAGGGACATCAGCGAGAGAGGCAGGGATCTTGAGCAG
ATTTTATCTCAGTACATTACGTTCGTCAAGCCTGCCTTTGAGGAATTCTGCTTGCCAACA
AAGAAGTATGCTGATGTGATCATCCCTAGAGGTGCAGATAATCTGGTGGCCATCAACCTC
ATCGTGCAGCACATCCAGGACATCCTGAATGGAGGGCCCTCCAAACGGCAGACCAATGGC
TGTCTCAACGGCTACACCCCTTCACGCAAGAGGCAGGCATCGGAGTCCAGCAGCAGGCCG
CATTGA

# Drug_Target_7_General_Function:
Nucleotide transport and metabolism

# Drug_Target_7_General_References:
11306702	Van Rompay AR, Norda A, Linden K, Johansson M, Karlsson A: Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases. Mol Pharmacol. 2001 May;59(5):1181-6.
11494055	Koizumi K, Shimamoto Y, Azuma A, Wataya Y, Matsuda A, Sasaki T, Fukushima M: Cloning and expression of uridine/cytidine kinase cDNA from human fibrosarcoma cells. Int J Mol Med. 2001 Sep;8(3):273-8.
8812458	Ozaki K, Kuroki T, Hayashi S, Nakamura Y: Isolation of three testis-specific genes (TSA303, TSA806, TSA903) by a differential mRNA display method. Genomics. 1996 Sep 1;36(2):316-9.

# Drug_Target_7_HGNC_ID:
HGNC:12562

# Drug_Target_7_HPRD_ID:
01882

# Drug_Target_7_ID:
2697

# Drug_Target_7_Locus:
1q23

# Drug_Target_7_Molecular_Weight:
29299

# Drug_Target_7_Name:
Uridine-cytidine kinase 2

# Drug_Target_7_Number_of_Residues:
261

# Drug_Target_7_PDB_ID:
1XRJ

# Drug_Target_7_Pathway:
Not Available

# Drug_Target_7_Pfam_Domain_Function:
PF00485	PRK

# Drug_Target_7_Protein_Sequence:
>Uridine-cytidine kinase 2
MAGDSEQTLQNHQQPNGGEPFLIGVSGGTASGKSSVCAKIVQLLGQNEVDYRQKQVVILS
QDSFYRVLTSEQKAKALKGQFNFDHPDAFDNELILKTLKEITEGKTVQIPVYDFVSHSRK
EETVTVYPADVVLFEGILAFYSQEVRDLFQMKLFVDTDADTRLSRRVLRDISERGRDLEQ
ILSQYITFVKPAFEEFCLPTKKYADVIIPRGADNLVAINLIVQHIQDILNGGPSKRQTNG
CLNGYTPSRKRQASESSSRPH

# Drug_Target_7_Reaction:
ATP + uridine = ADP + UMP

# Drug_Target_7_Signals:
None

# Drug_Target_7_Specific_Function:
Phosphorylates uridine and cytidine to uridine monophosphate and cytidine monophosphate. Does not phosphorylate deoxyribonucleosides or purine ribonucleosides. Can use ATP or GTP as a phosphate donor. Can also phosphorylate cytidine and uridine nucleoside analogs such as 6-azauridine, 5-fluorouridine, 4- thiouridine, 5-bromouridine, 4-N-acetylcytidine, 4-N- benzoylcytidine, 5-fluorocytidine, 2-thiocytidine, 5- methylcytidine, and 4-N-anisoylcytidine

# Drug_Target_7_SwissProt_ID:
Q9BZX2

# Drug_Target_7_SwissProt_Name:
UCK2_HUMAN

# Drug_Target_7_Synonyms:
Cytidine monophosphokinase 2
EC 2.7.1.48
UCK 2
Uridine monophosphokinase 2

# Drug_Target_7_Theoretical_pI:
6.68

# Drug_Target_7_Transmembrane_Regions:
None

# Drug_Target_8_Cellular_Location:
Not Available

# Drug_Target_8_Chromosome_Location:
Not Available

# Drug_Target_8_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_8_Essentiality:
Non-Essential

# Drug_Target_8_GenAtlas_ID:
Not Available

# Drug_Target_8_GenBank_ID_Gene:
L10328

# Drug_Target_8_GenBank_ID_Protein:
Not Available

# Drug_Target_8_GeneCard_ID:
Not Available

# Drug_Target_8_Gene_Name:
coaBC

# Drug_Target_8_Gene_Sequence:
Not Available

# Drug_Target_8_General_Function:
Coenzyme transport and metabolism

# Drug_Target_8_General_References:
6139280	Lundberg LG, Thoresson HO, Karlstrom OH, Nyman PO: Nucleotide sequence of the structural gene for dUTPase of Escherichia coli K-12. EMBO J. 1983;2(6):967-71.
7686882	Burland V, Plunkett G 3rd, Daniels DL, Blattner FR: DNA sequence and analysis of 136 kilobases of the Escherichia coli genome: organizational symmetry around the origin of replication. Genomics. 1993 Jun;16(3):551-61.
9278503	Blattner FR, Plunkett G 3rd, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, Gregor J, Davis NW, Kirkpatrick HA, Goeden MA, Rose DJ, Mau B, Shao Y: The complete genome sequence of Escherichia coli K-12. Science. 1997 Sep 5;277(5331):1453-74.

# Drug_Target_8_HGNC_ID:
Not Available

# Drug_Target_8_HPRD_ID:
Not Available

# Drug_Target_8_ID:
3692

# Drug_Target_8_Locus:
Not Available

# Drug_Target_8_Molecular_Weight:
43439

# Drug_Target_8_Name:
Coenzyme A biosynthesis bifunctional protein coaBC

# Drug_Target_8_Number_of_Residues:
406

# Drug_Target_8_PDB_ID:
Not Available

# Drug_Target_8_Pathway:
Not Available

# Drug_Target_8_Pfam_Domain_Function:
PF02441	Flavoprotein
PF04127	DFP

# Drug_Target_8_Protein_Sequence:
>Coenzyme A biosynthesis bifunctional protein coaBC
MSLAGKKIVLGVSGGIAAYKTPELVRRLRDRGADVRVAMTEAAKAFITPLSLQAVSGYPV
SDSLLDPAAEAAMGHIELGKWADLVILAPATADLIARVAAGMANDLVSTICLATPAPVAV
LPAMNQQMYRAAATQHNLEVLASRGLLIWGPDSGSQACGDIGPGRMLDPLTIVDMAVAHF
SPVNDLKHLNIMITAGPTREPLDPVRYISNHSSGKMGFAIAAAAARRGANVTLVSGPVSL
PTPPFVKRVDVMTALEMEAAVNASVQQQNIFIGCAAVADYRAATVAPEKIKKQATQGDEL
TIKMVKNPDIVAGVAALKDHRPYVVGFAAETNNVEEYARQKRIRKNLDLICANDVSQPTQ
GFNSDNNALHLFWQDGDKVLPLERKELLGQLLLDEIVTRYDEKNRR

# Drug_Target_8_Reaction:
CTP + (R)-4'-phosphopantothenate + L-cysteine = CMP + diphosphate + N-[(R)-4'-phosphopantothenoyl]-L-cysteine

# Drug_Target_8_Signals:
None

# Drug_Target_8_Specific_Function:
Catalyzes two steps in the biosynthesis of coenzyme A. In the first step cysteine is conjugated to 4'-phosphopantothenate to form 4-phosphopantothenoylcysteine, in the latter compound is decarboxylated to form 4'-phosphopantotheine

# Drug_Target_8_SwissProt_ID:
P0ABQ0

# Drug_Target_8_SwissProt_Name:
COABC_ECOLI

# Drug_Target_8_Synonyms:
CoaB]
CoaC
DNA/pantothenate metabolism flavoprotein[Includes: Phosphopantothenoylcysteine decarboxylase
EC 4.1.1.36
EC 6.3.2.5
PPC synthetase
PPCDC
PPCS
Phosphopantothenate-- cysteine ligase
Phosphopantothenoylcysteine synthase

# Drug_Target_8_Theoretical_pI:
7.58

# Drug_Target_8_Transmembrane_Regions:
None

#END_DRUGCARD DB02431
